Thus, HBV can target a variety of ongogenes (143) and regulate the expression of different miRNAs, interfering with multiple signaling pathways, including Wnt, MAPK, STAT, P53, Akt and Notch to promote HCC development (144–146). Here, TP53 is linked to hepatocellular carcinoma.